588 J . Org. Chem., Vol. 66, No. 2, 2001
Gauvry and Huet
ca r b on ylcycloh ex-2-en yl)a m in e (23a ) a n d It s (6R*)-
Isom er (23b). A solution of diene 20 (150 mg, 0.66 mmol),
methyl acrylate (0.75 mL, 6.60 mmol), and a trace of hydro-
quinone in toluene (2 mL) was heated in a sealed tube at 100
°C for 72 h. The reaction mixture was concentrated in vacuo.
The residue was purified by chromatography (silica gel,
cyclohexane/EtOAc, 4:1) to yield a mixture of adduct 23a and
23b (125 mg, 60%) in a 90:10 ratio as a colorless oil: IR (neat)
C6H5), 5.95 (m, 1H, H-2 or H-3), 5.74 (m, 1H, H-2 or H-3), 4.89
(dd, 1H, H-7, J ) 11.0, 8.7 Hz), 4.81 (dd, 1H, H-8, J ) 11.9,
3.8 Hz), 4.67 (dd, 1H, H-7′, J ) 11.0, 6.5 Hz), 4.53-4.42 (m,
3H, H-8′, H-9 and H-9′), 3.66 (m, 1H, H-1), 2.96 (m, 1H, H-4),
2.69 (m, 1H, H-5), 2.42 (m, 1H, H-6), 1.45 (br s, 2H, NH2); 13
C
NMR (CDCl3) δ 168.2, 168.1, 168.0, 134.7, 134.6, 134.5, 134.0,
131.9, 131.7, 131.6, 131.3, 131.2, 130.1, 130.0, 127.8, 67.5, 66.5,
64.0, 47.6, 43.4, 41.8, 36.9; HRMS calcd for C30H29NO6
499.1995, found 499.1998.
1
1716, 1705, cm-1; H NMR (CDCl3) major isomer 23a δ 5.95
(m, 1H, H-2), 5.86 (m, 1H, H-3), 4.69 (br d, 1H, NH, J ) 9.0
Hz), 4.58 (m, 1H, H-1), 3.71 (s, 3H, CH3), 3.68 (s, 3H, CH3),
3.12 (m, 1H, H-4), 2.76 (m, 1H, H-6), 2.19 (m, 1H, H-5), 1.94
(m, 1H, H-5′), 1.42 (s, 9H, (CH3)3), minor isomer 23b (partially
hidden by the major compound) δ 5.95-5.75 (m, 2H, H-2 and
H-3), 4.70-4.47 (m, 2H, NH and H-1), 3.70 (s, 3H, CH3), 3.69
(s, 3H, CH3), 3.23 (m, 1H, H-4), 2.76 (m, 1H, H-6), 2.19 (m,
1H, H-5), 1.94 (m, 1H, H-5′), 1.43 (s, 9H, (CH3)3); 13C NMR
(CDCl3) major isomer 23a δ 173.2, 172.9, 154.7, 128.2, 127.5,
79.6, 52.1, 51.8, 45.0, 42.9, 41.0, 28.2, 22.6, minor isomer 23b
(partially hidden by the major compound) δ 173.2, 172.9,
154.74, 129.2, 127.0, 79.6, 52.8, 52.1, 45.8, 43.3, 41.6, 28.2, 24.0;
HRMS calcd for [(C15H23NO6) + H - C4H9]+ 257.0895, found
257.0894.
(1R*,4S*,5S*,6S*)-N-ter t-Bu toxyca r bon yl[4,5,6-tr is(h y-
d r oxym eth yl)cycloh ex-2-en yl]a m in e (24). A solution of
adduct 22a (1.90 g, 5.84 mmol) in dry THF (15 mL) was added
dropwise to a cooled (0 °C) suspension of LiAlH4 (0.70 g, 0.17
mol) in dry THF (35 mL). The reaction mixture was refluxed
for 16 h and then cooled to -5 °C. A saturated solution of Na2-
SO4 (1.5 mL) was carefully added and, after addition of Et2O,
the suspension was stirred at room temperature for 15 min.
The precipitate was removed by filtration and washed with
THF and Et2O. The combined filtrates were concentrated in
vacuo, and the residue was dissolved in CH2Cl2. The solution
was dried over MgSO4, and the solvent was removed under
vacuum to give compound 24 (0.50 g, 78% crude) as a pale
yellow oil used in the next step without purification: IR (neat)
3600-3100, 1681 cm-1; 1H NMR (CDCl3) δ 5.81 (m, 1H, H-2),
5.72 (m, 1H, H-3), 5.56 (d, 1H, NH, J ) 16.4 Hz), 4.34 (m, 1H,
H-1), 3.84-3.50 (m, 9H, CH2 and OH), 2.61 (m, 1H, H-4), 2.14
(m, 1H, H-6), 1.96 (m, 1H, H-5), 1.45 (s, 9H, (CH3)3); 13C NMR
(CDCl3) δ 157.6, 130.8, 128.0, 80.2, 63.7, 62.6, 59.2, 44.0, 43.8,
41.7, 38.4, 28.3; HRMS calcd for C14H25NO5 287.1733, found
287.1729.
(1R *,4S *,5S *,6S *)-N -t er t -Bu t oxyca r b on yl[4,5,6-t r is-
(ben zoxym eth yl)cycloh ex-2-en yl]am in e (25). Pyridine (4.00
mL, 40.0 mmol) and benzoyl chloride (4.50 mL, 40.0 mmol)
were successively added to a cooled (0 °C) solution of crude
compound 24 (1.25 g, 4.35 mmol) in dry CH2Cl2. The reaction
mixture was stirred at room temperature for 16 h and diluted
with CH2Cl2. The solution was washed with 1 M aqueous HCl,
water, 10% NaHCO3, and brine. The aqueous layers were
extracted with CH2Cl2. The combined extracts were dried over
MgSO4 and concentrated in vacuo. The residue was purified
by chromatography (silica gel, CH2Cl2 then CH2Cl2/EtOAc, 95:
5) to afford compound 25 (1.33 g, 51%) as a colorless oil: IR
(neat) 1718, 1602 cm-1; 1H NMR (CDCl3) δ 8.12-7.94 (m, 6H,
C6H5), 7.63-7.32 (m, 9H, C6H5), 5.87 (m, 2H, H-2 and H-3),
4.70-4.53 (m, 6H, H-1, NH and CH2), 4.44 (m, 2H, CH2), 2.98
(m, 1H, H-4), 2.78 (m, 1H, H-5 or H-6), 2.64 (m, 1H, H-5 or
H-6), 1.36 (s, 9H, (CH3)3); 13C NMR (CDCl3) δ 171.2, 166.4,
166.3, 155.4, 133.5, 133.1, 133.0, 132.9, 130.1, 129.8, 129.7,
129.51, 129.49, 129.0, 128.4, 128.32, 128.28, 128.0, 79.8, 65.3,
(1R *,4S *,5S *,6S *)-N -[4,5-Bis(b e n zoxym e t h yl)-6-h y-
d r oxym eth ylcycloh ex-2-en yl]ben za m id e (27). If compound
26 was not rapidly used in the next step, it rearranged to give
compound 27: IR (neat) 3400-3200, 1714, 1643 cm-1; 1H NMR
(CDCl3) δ 8.06-7.26 (m, 15H, C6H5), 6.23 (d, 1H, NH, J ) 8.5
Hz), 6.03 (m, 2H, H-2 and H-3), 4.98 (m, 1H, H-1), 4.55 (dd,
1H, H-8, J ) 11.8, 5.0 Hz), 4.53-4.42 (m, 3H, H-9, H-9′ and
OH), 4.26 (dd, 1H, H-8′, J ) 11.8, 6.3 Hz), 3.87 (dd, 1H, H-7,
J ) 11.2, 11.2 Hz), 3.69 (dd, 1H, H-7′, J ) 11.2, 3.9 Hz), 3.09
(m, 1H, H-4), 2.60 (m, 1H, H-5), 2.43 (m, 1H, H-6); 13C NMR
(CDCl3) δ 169.0, 166.4, 166.3, 133.4, 133.2, 133.0, 132.0, 130.5,
129.7, 129.6, 129.5, 129.3, 128.7, 128.6, 128.4, 127.5, 126.9,
65.2, 62.4, 61.9, 44.7, 44.4, 39.9, 34.6.
(1R*,4S*,5S*,6S*)-[4,5,6-Tr is(ben zoxym eth yl)cycloh ex-
2-en yl]-3-(3-m eth oxya cr yloyl)u r ea (29). Thionyl chloride
(0.15 mL) was added to a solution of 3-methoxyacrylic acid
(120 mg, 1.20 mmol) in dry CH2Cl2 (1 mL). The reaction
mixture was refluxed for 3 h and concentrated to dryness. The
residue was dissolved in dry benzene, and AgOCN (0.31 g, 2.1
mmol) was added. The suspension was refluxed for 30 min to
afford 28 and cooled to 0 °C, and the supernatant liquor was
added to amine 26 (300 mg, 0.60 mmol). The mixture was
stirred at room temperature for 20 h and concentrated in
vacuo. The residue was purified by chromatography (silica gel,
cyclohexane/EtOAc, 1:1) to give compound 29 (263 mg, 70%)
as a white solid: mp 56-59 °C; IR (KBr) 1720, 1673 cm-1; 1H
NMR (CDCl3) δ 9.75 (s, 1H, NH), 9.01 (d, 1H, NH, J ) 9.8
Hz), 8.05-7.93 (m, 6H, C6H5), 7.55-7.29 (m, 10H, C6H5 and
H-3′′), 5.95 (m, 1H, H-2′ or H-3′), 5.88 (m, 1H, H-2′ or H-3′),
5.25 (d, 1H, H-2′′, J ) 12.3 Hz), 4.87 (m, 1H, H-1′), 4.79-4.48
(m, 6H, CH2), 3.62 (s, 3H, CH3), 2.99 (m, 1H, H-4′), 2.81 (m,
1H, H-5′ or H-6′), 2.70 (m, 1H, H-5′ or H-6′); 13C NMR (CDCl3)
δ 168.0, 166.27, 166.25, 166.20, 163.6, 155.1, 132.94, 132.86,
132.8, 130.1, 129.9, 129.8, 129.6, 129.5, 128.5, 128.3, 128.2,
128.1, 97.3, 65.3, 63.8, 61.6, 57.7, 44.1, 40.4, 39.4, 34.1; HRMS
calcd for [(C35H34N2O9) + H]+ 627.2343, found 627.2348.
(1R*,4S*,5S*,6S*)-1-[4,5,6-Tr is(h ydr oxym eth yl)cycloh ex-
2-en yl]u r a cil (30). A solution of compound 29 (100 mg, 0.16
mmol) in NH4OH 20% (1.5 mL) and MeOH (1.5 mL) was
heated in a sealed tube at 85 °C for 48 h. The mixture was
concentrated in vacuo, and the residue was purified by
chromatography (silica gel, CH2Cl2/MeOH, 9:1) to give com-
pound 30 (29 mg, 67%) as a yellow oil: IR 3500-3200, 1710,
1
1695 cm-1; H NMR (DMSO-d6) δ 11.14 (br s, 1H, NH), 7.38
(d, 1H, H-6, J ) 7.9 Hz), 6.14 (m, 1H, H-2′ or H-3′), 5.85 (m,
1H, H-2′ or H-3′), 5.48 (d, 1H, H-5, J ) 7.9 Hz), 5.07 (m, 1H,
H-1′), 3.56-3.19 (m, 9H, CH2 and OH), 2.38 (m, 2H, H-4′ and
H-6′), 2.12 (m, 1H, H-5′); 13C NMR (CD3OD) δ 168.3, 155.1,
146.6, 137.3, 127.1, 103.3, 64.9, 64.1, 61.1, 58.7, 42.6, 42.5, 42.4;
HRMS calcd for C13H18N2O5 282.1215, found 282.1216.
Ack n ow led gm en t. We thank Rhoˆne-Poulenc Rorer
Company for financial support and for evaluation of the
antitumor properties, Dr. M. Zucco (R.-P. R.) for useful
discussions, one of the referees and Dr. Simon Woo
(AstraZeneca R&D Montreal) for assistance with the
English language, and the local section of Sarthe of the
Ligue Nationale contre le Cancer for a fellowship to N.G.
63.7, 61.7, 45.4, 40.5, 39.2, 34.0, 28.2; HRMS calcd for [(C35H37
-
NO8) - C4H9 - CO2C6H5] 421.1519, found 421.1529.
(1R*,4S*,5S*,6S*)-[4,5,6-Tr is(ben zoxym eth yl)cycloh ex-
2-en yl]a m in e (26). Trifluoroacetic acid (5 mL) was added to
a solution of compound 25 (500 mg, 0.83 mmol) in CH2Cl2 (5
mL). The reaction mixture was stirred at room temperature
for 1.5 h and then cooled to 0 °C. A 20% NaOH solution was
carefully added until pH 10, and the mixture was extracted
with CH2Cl2. The combined extracts were dried over K2CO3,
and the solvent was removed under reduced pressure to give
Su p p or tin g In for m a tion Ava ila ble: 1H NMR spectra of
compounds 16-21, 22a , 23-27, 29, and 30, and several NOE
spectra of 18, 20, 22a , and 23a . This material is available free
1
26 (371 mg, 89%) as a colorless oil: IR (neat) 1727 cm-1; H
NMR (CDCl3) δ 8.06-7.94 (m, 6H, C6H5), 7.59-7.28 (m, 9H,
J O001467V